Primecap Management CO Xencor Inc Transaction History

Primecap Management CO

$134 Billion
Q3 2024

A detailed history of Primecap Management CO transactions in Xencor Inc stock. As of the latest transaction made, Primecap Management CO holds 9,137,195 shares of XNCR stock, worth $220 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

9,137,195

Previous 9,116,202 0.23%

Holding current value

$220 Million

Previous $173 Million 6.48%

% of portfolio

0.14%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$15.7 - $21.65 $329,590 - $454,498	20,993 Added 0.23%	9,137,195 $184 Million
Q2 2024 Aug 09, 2024	BUY	$18.21 - $24.5 $464,263 - $624,627	25,495 Added 0.28%	9,116,202 $173 Million
Q1 2024 May 13, 2024	BUY	$18.65 - $26.52 $3.53 Million - $5.01 Million	189,100 Added 2.12%	9,090,707 $201 Million
Q4 2023 Feb 09, 2024	BUY	$16.53 - $21.42 $11.9 Million - $15.4 Million	717,401 Added 8.77%	8,901,607 $189 Million
Q3 2023 Nov 13, 2023	BUY	$20.08 - $25.39 $8.7 Million - $11 Million	433,354 Added 5.59%	8,184,206 $165 Million
Q2 2023 Aug 11, 2023	BUY	$24.77 - $29.9 $4.66 Million - $5.62 Million	188,033 Added 2.49%	7,750,852 $194 Million
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $34.9 Million - $49.7 Million	1,345,916 Added 21.65%	7,562,819 $211 Million
Q4 2022 Feb 13, 2023	BUY	$24.79 - $30.86 $13.1 Million - $16.3 Million	526,672 Added 9.26%	6,216,903 $162 Million
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $22 Million - $29 Million	895,179 Added 18.67%	5,690,231 $148 Million
Q2 2022 Aug 11, 2022	SELL	$19.74 - $29.01 $2.89 Million - $4.25 Million	-146,560 Reduced 2.97%	4,795,052 $131 Million
Q1 2022 May 11, 2022	SELL	$26.68 - $41.63 $1.23 Million - $1.92 Million	-46,210 Reduced 0.93%	4,941,612 $132 Million
Q4 2021 Feb 11, 2022	SELL	$33.67 - $43.44 $9.7 Million - $12.5 Million	-288,010 Reduced 5.46%	4,987,822 $200 Million
Q3 2021 Nov 12, 2021	SELL	$30.65 - $35.68 $638,746 - $743,571	-20,840 Reduced 0.39%	5,275,832 $172 Million
Q2 2021 Aug 10, 2021	SELL	$34.33 - $44.68 $550,996 - $717,114	-16,050 Reduced 0.3%	5,296,672 $183 Million
Q1 2021 May 14, 2021	SELL	$40.81 - $53.88 $1.13 Million - $1.49 Million	-27,700 Reduced 0.52%	5,312,722 $229 Million
Q4 2020 Feb 08, 2021	SELL	$36.63 - $47.63 $2.48 Million - $3.23 Million	-67,710 Reduced 1.25%	5,340,422 $233 Million
Q3 2020 Nov 13, 2020	SELL	$30.09 - $43.02 $3.63 Million - $5.19 Million	-120,740 Reduced 2.18%	5,408,132 $210 Million
Q2 2020 Aug 13, 2020	SELL	$27.76 - $33.42 $4.76 Million - $5.73 Million	-171,500 Reduced 3.01%	5,528,872 $179 Million
Q1 2020 May 14, 2020	SELL	$20.69 - $37.79 $16.7 Million - $30.5 Million	-806,941 Reduced 12.4%	5,700,372 $170 Million
Q4 2019 Feb 14, 2020	SELL	$32.75 - $41.43 $15.9 Million - $20.1 Million	-484,898 Reduced 6.93%	6,507,313 $224 Million
Q3 2019 Nov 13, 2019	SELL	$33.73 - $46.27 $15.5 Million - $21.3 Million	-460,372 Reduced 6.18%	6,992,211 $236 Million
Q2 2019 Aug 14, 2019	SELL	$29.6 - $40.93 $1.52 Million - $2.1 Million	-51,300 Reduced 0.68%	7,452,583 $305 Million
Q1 2019 May 14, 2019	SELL	$27.85 - $38.09 $3.04 Million - $4.16 Million	-109,100 Reduced 1.43%	7,503,883 $233 Million
Q4 2018 Feb 12, 2019	SELL	$32.39 - $42.05 $283,736 - $368,358	-8,760 Reduced 0.11%	7,612,983 $275 Million
Q3 2018 Nov 13, 2018	BUY	$35.69 - $47.65 $1.96 Million - $2.61 Million	54,800 Added 0.72%	7,621,743 $297 Million
Q2 2018 Aug 13, 2018	BUY	$28.41 - $42.41 $2.59 Million - $3.87 Million	91,300 Added 1.22%	7,566,943 $280 Million
Q1 2018 May 14, 2018	BUY	$21.18 - $33.78 $27.9 Million - $44.5 Million	1,317,400 Added 21.39%	7,475,643 $224 Million
Q4 2017 Feb 13, 2018	BUY	$19.29 - $24.83 $526,617 - $677,859	27,300 Added 0.45%	6,158,243 $135 Million
Q3 2017 Nov 13, 2017	BUY	$19.61 - $23.35 $120 Million - $143 Million	6,130,943	6,130,943 $141 Million

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Xencor Inc Transaction History